BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Diagnosis
14 results:

  • 1. [A Case Report of Metastatic Breast cancer with Peritoneal Metastasis and Massive Ascites Responding to cdk4/6 Inhibitor(Palbociclib)].
    Yao S; Goi T; Takahashi M; Kono H; Yokoi S; Maeda H
    Gan To Kagaku Ryoho; 2024 Feb; 51(2):214-216. PubMed ID: 38449417
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Recurrent Breast cancer with Bone Metastasis Effectively Treated with Abemaciclib plus Endocrine Therapy-A Case Report].
    Adachi K; Nagae J; Kubota H; Suzuki S; Hirano T; Sakurai K
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1845-1847. PubMed ID: 38303227
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Trichodermin Induces G0/G1 Cell Cycle Arrest by Inhibiting c-Myc in ovarian cancer Cells and Tumor Xenograft-Bearing Mice.
    Gao Y; Miles SL; Dasgupta P; Rankin GO; Cutler S; Chen YC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34065149
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer.
    de Boer R; Hui R; Lim E; Yeo B; Zdenkowski N
    Asia Pac J Clin Oncol; 2020 Nov; 16 Suppl 5():3-14. PubMed ID: 33137857
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A high serum-free fatty acid level is associated with cancer.
    Zhang L; Han L; He J; Lv J; Pan R; Lv T
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):705-710. PubMed ID: 31773260
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer.
    Lange CA; Yee D
    Endocr Relat Cancer; 2011 Aug; 18(4):C19-24. PubMed ID: 21613412
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), cdk4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
    Buecher B; Gauthier-Villars M; Desjardins L; Lumbroso-Le Rouic L; Levy C; De Pauw A; Bombled J; Tirapo C; Houdayer C; Bressac-de Paillerets B; Stoppa-Lyonnet D
    Fam Cancer; 2010 Dec; 9(4):663-7. PubMed ID: 20842456
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus.
    Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Hillemanns P; Dörk T
    Clin Genet; 2010 Oct; 78(4):364-72. PubMed ID: 20569256
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.
    Yang G; Rosen DG; Liu G; Yang F; Guo X; Xiao X; Xue F; Mercado-Uribe I; Huang J; Lin SH; Mills GB; Liu J
    Clin Cancer Res; 2010 Aug; 16(15):3875-86. PubMed ID: 20505188
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
    ; Beral V; Doll R; Hermon C; Peto R; Reeves G
    Lancet; 2008 Jan; 371(9609):303-14. PubMed ID: 18294997
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
    Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
    Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictors of comprehensive surgical treatment in patients with ovarian cancer.
    Goff BA; Matthews BJ; Larson EH; Andrilla CH; Wynn M; Lishner DM; Baldwin LM
    Cancer; 2007 May; 109(10):2031-42. PubMed ID: 17420977
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
    Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
    Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The effect of tubal ligation on the incidence of epithelial cancer of the ovary.
    Koch M; Starreveld AA; Hill GB; Jenkins H
    Cancer Detect Prev; 1984; 7(4):241-5. PubMed ID: 6488215
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.